Last update 01 Nov 2024

Linton Pacific Ag

Overview

Tags

Digestive System Disorders
Neoplasms
Other Diseases
Bispecific T-cell Engager (BiTE)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Bispecific T-cell Engager (BiTE)1
Top 5 TargetCount
CD3 x EpCAM1

Related

1
Drugs associated with Linton Pacific Ag
Catumaxomab
Target
CD3 x EpCAM
Mechanism
CD3 stimulants [+3]
Active Org.
Linton Pacific Ag [+3]
Originator Org.
Neovii Biotech GmbHNeovii Biotech GmbH
Active Indication
Malignant ascites [+3]
Inactive Indication
Carcinoma [+8]
Drug Highest PhaseNDA/BLA
First Approval Ctry. / Loc.
EU [+3]
First Approval Date20 Apr 2009
2
Clinical Trials associated with Linton Pacific Ag
CTR20210616 / RecruitingPhase 1/2
一项观察卡妥索单抗对卡介苗治疗失败或不耐受的非肌层浸润性膀胱癌患者的安全性与初步有效性的多中心，非随机，非对照，开放I/II期研究
[Translation] A multicenter, non-randomized, non-controlled, open-label phase I/II study to observe the safety and preliminary efficacy of catumaxomab in patients with non-muscle invasive bladder cancer who have failed or are intolerant to BCG therapy
CTR20201246 / RecruitingPhase 1
比较卡妥索单抗与研究者选择治疗对伴腹膜转移晚期胃癌患者的有效性与安全性的多中心，开放，随机对照研究
[Translation] A multicenter, open, randomized controlled study comparing the efficacy and safety of catumaxomab versus investigator's choice of therapy in patients with advanced gastric cancer and peritoneal metastasis
100 Clinical Results associated with Linton Pacific Ag
Login to view more data
0 Patents (Medical) associated with Linton Pacific Ag
Login to view more data
100 Deals associated with Linton Pacific Ag
Login to view more data
100 Translational Medicine associated with Linton Pacific Ag
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Catumaxomab
 ( CD3 x EpCAM )		Non-Muscle Invasive Bladder Neoplasms
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free